EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Berberine Suppression of Human IgE but Not IgG Production via Inhibition of STAT6 Binding Activity at IgE Promoter by BCL6

Anish R Maskey iD, Michelle Carnazza, Madison Spears, Steven Hemmindinger, Daniel Kopulos iD, Nan Yang, Humayun K Islam, Augustine L Moscatello, Jan Geliebter iD, Raj K Tiwari, Xiu-Min Li

Cells · 2025

DOI: 10.3390/cells14080591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Anish R Maskey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA. Hauptthemen laut MEDLINE: Immunoglobulin E, Immunoglobulin G, STAT6 Transcription Factor, Proto-Oncogene Proteins c-bcl-6. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgE may lead to life-threatening anaphylaxis. Currently, no satisfactory treatment to inhibit IgE production exists. This study aims to explore the anti-IgE effect of berberine (BBR) and possible mechanisms using human tonsil cells. Tonsil cells were treated with BBR at different doses following stimulation with anti-CD40/IL4 alone or in combination with poly I:C and Pam3CSK4 for 10 or 4 days. IgE and IgG levels were determined by ELISA and cell viability by trypan blue exclusion. Gene expression was analyzed by qRT-PCR and affinity binding assay was performed by chromatin immunoprecipitation assay (ChIP). BBR showed dose-dependent inhibition of IgE production following anti-CD40/IL4 stimulation without affecting cell viability and IgG levels. BBR (10 µg/mL) completely inhibited IgE production by B cells stimulated with anti-CD40/IL4 in combination with vaccine adjuvants—poly I:C and Pam3CSK4 without affecting IgG levels and cell viability. BBR inhibited IgE heavy chain (IgEh), epsilon germline-transcript (εGLT), STAT6, and NFκB1 and enhanced IFN-γ, NFκB1A, and BCL6 gene expression. ChIP assay showed that BBR inhibited STAT6 binding in the IgEh promoter region by enhancing BCL6 binding. This study shows BBR regulates IgE in human tonsil cells by inhibiting STAT6 binding through BCL6 at the IgEh promoter showing its potential for treating IgE-mediated allergies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin EImmunoglobulin GSTAT6 Transcription FactorProto-Oncogene Proteins c-bcl-6BerberinePromoter Regions, GeneticHumansProtein BindingCell SurvivalB-Lymphocytes

Stichwörter der Autor:innen

BCL6IgESTAT6anti-CD40/IL4tonsils

Substanzen

Immunoglobulin EImmunoglobulin GSTAT6 Transcription FactorProto-Oncogene Proteins c-bcl-6BerberineSTAT6 protein, humanBCL6 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA.
  • Division of R&D, General Nutraceutical Technology LLC., Elmsford, NY 10523, USA.
  • Department of Otorhinolaryngology, Westchester Medical Center, Valhalla, NY 10595, USA.
  • Department of Pathology, Westchester Medical Center, Valhalla, NY 10595, USA.
  • Department of Dermatology, New York Medical College, Valhalla, NY 10595, USA.

ORCID-Profile: Anish R Maskey, Daniel Kopulos, Jan Geliebter

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)

Zitieren

APA

Maskey, A. R., Carnazza, M., Spears, M., Hemmindinger, S., Kopulos, D., Yang, N., Islam, H. K., Moscatello, A. L., Geliebter, J., Tiwari, R. K., & Li, X. M. (2025). Berberine Suppression of Human IgE but Not IgG Production via Inhibition of STAT6 Binding Activity at IgE Promoter by BCL6. Cells. https://doi.org/10.3390/cells14080591

Vancouver

Maskey AR, Carnazza M, Spears M, Hemmindinger S, Kopulos D, Yang N, et al. Berberine Suppression of Human IgE but Not IgG Production via Inhibition of STAT6 Binding Activity at IgE Promoter by BCL6. Cells. 2025. doi:10.3390/cells14080591

BibTeX
@article{Maskey2025,
  author = {Maskey, Anish R and Carnazza, Michelle and Spears, Madison and Hemmindinger, Steven and Kopulos, Daniel and Yang, Nan and Islam, Humayun K and Moscatello, Augustine L and Geliebter, Jan and Tiwari, Raj K and Li, Xiu-Min},
  title = {Berberine Suppression of Human IgE but Not IgG Production via Inhibition of STAT6 Binding Activity at IgE Promoter by BCL6},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14080591}
}
Kostenlos starten →